Rachel J. Cook

3.3k total citations · 1 hit paper
43 papers, 818 citations indexed

About

Rachel J. Cook is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Rachel J. Cook has authored 43 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 13 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Rachel J. Cook's work include Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Rachel J. Cook is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Rachel J. Cook collaborates with scholars based in United States, France and Australia. Rachel J. Cook's co-authors include Laura F. Newell, Jay H. Ryu, Rendell W. Ashton, Gregory L. Aughenbaugh, Carol Diamond, Scott B. Reeder, Diego Hernando, Richard D. Press, Richard T. Maziarz and Gabrielle Meyers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Rachel J. Cook

37 papers receiving 800 citations

Hit Papers

Advances in acute myeloid... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel J. Cook United States 12 376 256 171 154 122 43 818
Suzanne Tavitian France 14 463 1.2× 200 0.8× 172 1.0× 62 0.4× 124 1.0× 59 857
Anu Korula India 14 394 1.0× 202 0.8× 102 0.6× 74 0.5× 142 1.2× 112 724
Hassan B. Alkhateeb United States 14 502 1.3× 190 0.7× 222 1.3× 67 0.4× 125 1.0× 148 743
Roni Tamari United States 18 601 1.6× 161 0.6× 205 1.2× 176 1.1× 127 1.0× 98 977
Gaurav Prakash India 15 286 0.8× 144 0.6× 184 1.1× 60 0.4× 67 0.5× 173 818
Jean Norden United Kingdom 18 432 1.1× 261 1.0× 84 0.5× 155 1.0× 71 0.6× 45 1.0k
Mi Kwon Spain 19 547 1.5× 158 0.6× 98 0.6× 119 0.8× 154 1.3× 113 1.1k
Angela R. Smith United States 19 425 1.1× 371 1.4× 134 0.8× 129 0.8× 161 1.3× 50 1.1k
Tarja‐Terttu Pelliniemi Finland 20 450 1.2× 272 1.1× 80 0.5× 94 0.6× 161 1.3× 37 871
Valérie Coiteux France 16 351 0.9× 290 1.1× 182 1.1× 131 0.9× 83 0.7× 55 836

Countries citing papers authored by Rachel J. Cook

Since Specialization
Citations

This map shows the geographic impact of Rachel J. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel J. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel J. Cook more than expected).

Fields of papers citing papers by Rachel J. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel J. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel J. Cook. The network helps show where Rachel J. Cook may publish in the future.

Co-authorship network of co-authors of Rachel J. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel J. Cook. A scholar is included among the top collaborators of Rachel J. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel J. Cook. Rachel J. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarado, Yesid, Rachel J. Cook, Shira Dinner, et al.. (2025). The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia. PubMed. 2(3). 100108–100108. 1 indexed citations
3.
Maziarz, Richard T. & Rachel J. Cook. (2024). The rationale behind grafting haploidentical hematopoietic stem cells. Hematology. 29(1). 2347673–2347673. 1 indexed citations
4.
Cook, Rachel J., Shira Dinner, Michael Keng, et al.. (2024). A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML). Blood. 144(Supplement 1). 2878–2878. 2 indexed citations
6.
Zeidan, Amer M., Rachel J. Cook, Rodolfo Bordoni, et al.. (2022). A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22(7). 523–534. 10 indexed citations
7.
Borate, Uma, Andy Kaempf, Jessica Minnier, et al.. (2021). FLT3-Mutated Acute Myeloid Leukemia Using a Novel Regimen of Gemtuzumab Ozogamicin and Midostaurin in Combination with Standard Cytarabine and Daunorubicin Induction Therapy. Blood. 138(Supplement 1). 1269–1269. 2 indexed citations
8.
Newell, Laura F. & Rachel J. Cook. (2021). Advances in acute myeloid leukemia. BMJ. 375. n2026–n2026. 289 indexed citations breakdown →
9.
Newell, Laura F., Jennifer Dunlap, Ken Gatter, et al.. (2021). Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations. American Journal of Transplantation. 21(12). 3894–3906. 12 indexed citations
10.
Hernando, Diego, et al.. (2020). Complex confounder-corrected R2* mapping for liver iron quantification with MRI. European Radiology. 31(1). 264–275. 30 indexed citations
11.
Lachowiez, Curtis A., Rachel J. Cook, Brandon Hayes‐Lattin, et al.. (2019). Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years. Hematology/Oncology and Stem Cell Therapy. 12(2). 105–109. 5 indexed citations
13.
Cook, Rachel J., Jennifer Gill, & Vinay Prasad. (2019). Registration studies — when should patients be deemed ineligible for aggressive therapy?. Nature Reviews Clinical Oncology. 16(6). 333–334. 2 indexed citations
14.
Bixby, Dale L., Carlos E. Vigil, Joseph G. Jurcic, et al.. (2017). Pharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarotene) in biomarker-selected acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients. Annals of Oncology. 28. v367–v367. 1 indexed citations
15.
Cook, Rachel J. & Lyndsey Runaas. (2016). The Difficulties of Informed Consent in Stem Cell Transplant. Current Hematologic Malignancy Reports. 11(1). 1–5. 8 indexed citations
16.
Hernando, Diego, Rachel J. Cook, Carol Diamond, & Scott B. Reeder. (2013). Magnetic susceptibility as aB0field strength independent MRI biomarker of liver iron overload. Magnetic Resonance in Medicine. 70(3). 648–656. 34 indexed citations
17.
West, Colin P., et al.. (2007). Perceived Impact of Duty Hours Regulations: A Survey of Residents and Program Directors. The American Journal of Medicine. 120(7). 644–648. 10 indexed citations
18.
Cook, Rachel J., James D. Hoyer, & W. Edward Highsmith. (2006). Quintuple α-Globin Gene: A Novel Allele in a Sudanese Man. Hemoglobin. 30(1). 51–55. 5 indexed citations
19.
Cook, Rachel J., Rendell W. Ashton, Gregory L. Aughenbaugh, & Jay H. Ryu. (2005). Septic Pulmonary Embolism. CHEST Journal. 128(1). 162–166. 162 indexed citations
20.
Riegert‐Johnson, Douglas L., Charles J. Bruce, Víctor M. Montori, Rachel J. Cook, & Peter C. Spittell. (2005). Residents Can Be Trained to Detect Abdominal Aortic Aneurysms Using Personal Ultrasound Imagers: A Pilot Study. Journal of the American Society of Echocardiography. 18(5). 394–397. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026